Scientific article

Oxygénothérapie à domicile

Published inRevue médicale suisse, vol. 19, no. 850, p. 2153-2158
Publication date2023-11-15

Only severe hypoxemia at rest in COPD patients has strong recommendations for long-term oxygen therapy. It is accepted that oxygen should be prescribed if PaO2 is ≤ 7,3 kPa (55 mmHg), or if PaO2 is ≤ 8 kPa (60 mmHg) in the presence of signs of pulmonary hypertension or a hematocrit ≥ 55 %. In Switzerland, prescription is governed by the LiMA (Liste des moyens et appareils) and the patient can obtain supplies from a health care provider or directly from the provider. The most suitable device taking patient's oxygen needs and mobility into account must be chosen. O2 prescription entails risks for the patient that must be known to the prescriber. This article presents the different aspects of long-term home oxygen therapy.

  • Humans
  • Oxygen Inhalation Therapy
  • Oxygen / therapeutic use
  • Hypoxia / etiology
  • Hypoxia / therapy
  • Hypoxia / diagnosis
  • Hypertension, Pulmonary / therapy
  • Prescriptions
Citation (ISO format)
BRÜGGER, Baptiste et al. Oxygénothérapie à domicile. In: Revue médicale suisse, 2023, vol. 19, n° 850, p. 2153–2158. doi: 10.53738/REVMED.2023.19.850.2153
Main files (1)
Article (Published version)
accessLevelRestrictedaccessLevelPublic 05/16/2025
ISSN of the journal1660-9379

Technical informations

Creation01/09/2024 9:52:38 AM
First validation03/13/2024 2:27:38 PM
Update time03/13/2024 2:27:38 PM
Status update03/13/2024 2:27:38 PM
Last indexation03/13/2024 2:27:59 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack